Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
INTERFACE INCInterface, Inc. Reports 5.4% Revenue Growth to $395.7 Million in Q2 Fiscal 2026
Neutron Holdings, Inc.Neutron Holdings Reports 24% Revenue Growth and Significant Net Income Increase in Latest Quarter
Global Arena Holding, Inc.Global Arena Holding Reports 30% Revenue Increase but Continues to Face Operational Losses in Q3 2025
Immunome Inc.Immunome Reports $73.1 Million Net Loss in Q2 2026, Increased R&D Expenses
Aquestive Therapeutics, Inc.Aquestive Therapeutics Reports 38% Revenue Growth in Q2 2026, Despite Increased Net Loss
Energy Vault Holdings, Inc.Energy Vault Reports 104% Revenue Growth to $17.4 Million in Q2 2026
NEXTNAV INC.NextNav Inc. Reports Q2 2026 Revenue Decline and Increased Operating Expenses
ACHIEVE LIFE SCIENCES, INC.Achieve Life Sciences Reports $84.9 Million Net Loss and Faces Regulatory Challenges
Absci CorpAbsci Corporation Reports Decrease in Revenue and Increase in Net Losses for Q2 2026
PLIANT THERAPEUTICS, INC.Pliant Therapeutics Reports $22.4 Million Net Loss in Q2 2026, Down from $43.3 Million Last Year
Gain Therapeutics, Inc.Gain Therapeutics Reports $4.7 Million Net Loss in Q2 2026, Progress on Rexaceract Development
Taysha Gene Therapies, Inc.Taysha Gene Therapies Reports Zero Revenue and Increased Losses in Q2 2026
Anterix Inc.Anterix Reports Decline in Net Income Despite Increase in Spectrum Revenue for Q2 2026
Erasca, Inc.Erasca Reports $44.1 Million Net Loss in Q2 2026, Driven by Increased R&D Expenses
Dermata Therapeutics, Inc.Dermata Therapeutics Reports $2.97 Million Net Loss in Q2 2026, Shifts Focus to Skincare Products
Kyverna Therapeutics, Inc.Kyverna Therapeutics Reports Q2 2026 Financial Results with Reduced Net Loss
IZEA Worldwide, Inc.IZEA Worldwide Reports 36% Revenue Decline and Net Loss in Q2 2026
Hoyne Bancorp, Inc.Hoyne Bancorp Reports Q2 2026 Financial Results with Decreased Net Income
REVVITY, INC.Revvity Reports $729.7 Million Revenue in Q2 2026, Driven by Diagnostics Growth
ARK RESTAURANTS CORPArk Restaurants Corp. Reports 8% Revenue Decline and Operating Loss Improvement
Bolt Biotherapeutics, Inc.Bolt Biotherapeutics Reports Q2 2026 Financial Results with $7.7M Net Loss
Janus International Group, Inc.Janus International Group Reports Q2 2026 Financial Results with Revenue Growth and Decreased Net Income
ACCESS Newswire Inc.ACCESS Newswire Reports Slight Revenue Decline and Increased Operating Expenses in Q2 2026
GSI TECHNOLOGY INCGSI Technology Reports $6.3M Revenue and $4.8M Net Loss for Q2 2026
K&F GROWTH ACQUISITION CORP. IIK&F Growth Acquisition Corp. II Reports Decrease in Net Income and Increased Accumulated Deficit for Quarter Ending June 30, 2026